Acknowledgements
References
-
1.
Moore TJ, Mattison DR. Assessment of patterns of potentially unsafe use of zolpidem. JAMA Intern Med. 2018;178(9):1275-7. [PubMed ID: 30014137]. [PubMed Central ID: PMC6583219]. https://doi.org/10.1001/jamainternmed.2018.3031.
-
2.
Kesselheim AS, Sinha MS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, et al. Multimodal analysis of FDA drug safety communications: Lessons from zolpidem. Drug Saf. 2019;42(11):1287-95. [PubMed ID: 31302895]. https://doi.org/10.1007/s40264-019-00849-8.
-
3.
Netzel CL, Abd-Elsayed A. Benzodiazepines. Pain. Springer; 2019. p. 289-92. https://doi.org/10.1007/978-3-319-99124-5_63.
-
4.
Jang Y, Song I, Oh IS, Shin JY. Twelve-year trend in the use of zolpidem and physicians' non-compliance with recommended duration: A Korean national health insurance database study. Eur J Clin Pharmacol. 2019;75(1):109-17. [PubMed ID: 30280207]. https://doi.org/10.1007/s00228-018-2563-9.
-
5.
Mortaz Hejri S, Faizi M, Babaeian M. Zolpidem-induced suicide attempt: A case report. Daru. 2013;21(1):77. [PubMed ID: 24359886]. [PubMed Central ID: PMC3878174]. https://doi.org/10.1186/2008-2231-21-77.
-
6.
Haji Seyed Javadi SA, Hajiali F, Nassiri-Asl M. Zolpidem dependency and withdrawal seizure: A case report study. Iran Red Crescent Med J. 2014;16(11). e19926. [PubMed ID: 25763219]. [PubMed Central ID: PMC4329938]. https://doi.org/10.5812/ircmj.19926.
-
7.
Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P. Evidence of zolpidem abuse and dependence: Results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol. 2007;64(2):198-209. [PubMed ID: 17324242]. [PubMed Central ID: PMC2000636]. https://doi.org/10.1111/j.1365-2125.2007.02861.x.
-
8.
Hsu J, Lin JJ, Tsay WI. Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011. J Food Drug Anal. 2014;22(2):169-77. https://doi.org/10.1016/j.jfda.2014.01.019.
-
9.
Rahimi Pordanjani S, Fallah Zadeh H, Mousavi M, Khazaei S, Sohrabivafa M, Momenabadi V, et al. Prevalence and reasons for psychoactive drugs use among university students of medical sciences in Yazd, Iran. Iran J Psychiatr Behav Sci. 2018;12(1). e9384. https://doi.org/10.5812/ijpbs.9384.
-
10.
Holm KJ, Goa KL. Zolpidem: An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs. 2000;59(4):865-89. [PubMed ID: 10804040]. https://doi.org/10.2165/00003495-200059040-00014.